Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024

Go back to Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024

Quest Diagnostics (DGX) Tops Q1 EPS by 18c, Beats on Revenue; Offers FY24 Guidance

April 23, 2024 6:47 AM EDT

Quest Diagnostics (NYSE: DGX) reported Q1 EPS of $2.04, $0.18 better than the analyst estimate of $1.86. Revenue for the quarter came in at $2.37 billion versus the consensus estimate of $2.29 billion.

GUIDANCE:

Quest Diagnostics sees FY2024 EPS of $8.72-$8.97, versus the consensus of $8.75.... More